Physician profile
Zuri A Murrell
NPI 1881625267
$85,615.60
in general payments reported to CMS, 2019-2025
35 companies · $32K in 2025
The $32K reported for 2025 was more than what 97% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,428 · 2020: $12K · 2021: $1,944 · 2022: $2,282 · 2023: $1,257 · 2024: $34K · 2025: $32K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $57K · Food and Beverage: $5,318 · Travel and Lodging: $4,172 · Consulting Fee: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $57,194.56 |
| Food and Beverage | $5,317.54 |
| Travel and Lodging | $4,171.58 |
| Consulting Fee | $600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $46,929.24 | 2019-2025 | Wegovy |
| Pfizer INC. | $15,000.00 | 2025 | |
| Palette Life Sciences, INC. | $14,358.11 | 2019-2023 | |
| Biotissue Holdings INC. | $3,690.17 | 2024-2025 | |
| Thd America, INC. | $1,737.65 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $776.43 | 2021-2025 | Relistor |
| Ferring Pharmaceuticals INC. | $534.51 | 2019-2023 | Clenpiq, Rebyota |
| Axonics, INC. | $430.00 | 2022-2023 | Axonics |
| Medtronic, INC. | $340.56 | 2023-2025 | Interstim, Infinity Occipitocervical Upper Thoracic System |
| Endo Pharmaceuticals INC. | $303.83 | 2019-2022 | |
| Teleflex LLC | $244.86 | 2024 | Solesta |
| Takeda Pharmaceuticals U.S.A., INC. | $136.77 | 2019-2023 | Gattex |
| Myriad Genetic Laboratories, INC. | $135.20 | 2024 | Myrisk |
| Lilly USA, LLC | $119.80 | 2024-2025 | Zepbound |
| Prescient Surgical | $116.50 | 2019-2020 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $115.03 | 2019-2020 | |
| Exact Sciences Corporation | $95.90 | 2023 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $64.00 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $60.23 | 2019-2024 | Andexxa |
| Braintree Laboratories, INC. | $55.29 | 2019-2021 | |
| Daiichi Sankyo INC. | $42.85 | 2019 | |
| Bausch Health US, LLC | $37.58 | 2021 | |
| Trevena, INC. | $34.60 | 2021 | |
| Convatec INC. | $33.65 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $33.55 | 2025 | |
| Medtronic USA, INC. | $29.41 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $23.28 | 2024 | Exparel |
| Covidien LP | $23.07 | 2019 | |
| Innovation Technologies INC | $22.84 | 2024 | Irrisept |
| Olympus America INC. | $18.69 | 2019 | |
| Zyla Life Sciences, INC. | $18.44 | 2020 | |
| Acell, INC. | $16.69 | 2019 | |
| Shionogi INC | $13.09 | 2019 | |
| Smith+Nephew, INC. | $12.00 | 2020 | |
| Ethicon US, LLC | $11.78 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zuri Murrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.